What question did this study set out to answer?

To evaluate the efficacy and safety of repeated low-level red-light therapy for myopia control.

Repeated low-level red-light therapy for myopia control: An update on efficacy and safety

View Full Paper

Ask AI

Bookmark

To evaluate the efficacy and safety of repeated low-level red-light therapy for myopia control.
Reviewed high-level evidence from randomized controlled trials and meta-analyses on RLRL therapy.
Evaluated axial elongation reduction and myopic progression in children receiving therapy.
Assessed safety through reported adverse effects and clinical significance of observed changes.
RLRL therapy significantly reduces axial elongation and slows myopic progression in children.
Network meta-analyses indicate superior efficacy of RLRL compared to established myopia interventions.
Short-term safety profile is favorable without reports of irreversible damage.

No takes yet. Share an insight, caveat, or question.

Randomized trial demonstrates reduced myopia progression in children with low-level red-light therapy, suggesting it may be a safe intervention.

Wu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial demonstrates reduced myopia progression in children with low-level red-light therapy, suggesting it may be a safe intervention.